Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT06427083 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06427083
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-11
- Primary completion
- 2025-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.